BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29573058)

  • 1. Molecular genomic landscapes of hepatobiliary cancer.
    Shibata T; Arai Y; Totoki Y
    Cancer Sci; 2018 May; 109(5):1282-1291. PubMed ID: 29573058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
    Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
    J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation.
    Haines K; Sarabia SF; Alvarez KR; Tomlinson G; Vasudevan SA; Heczey AA; Roy A; Finegold MJ; Parsons DW; Plon SE; López-Terrada D
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27745. PubMed ID: 30977242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of hepatocarcinogenesis.
    Shibata T
    J Hum Genet; 2021 Sep; 66(9):845-851. PubMed ID: 33958712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
    ;
    Cell; 2017 Jun; 169(7):1327-1341.e23. PubMed ID: 28622513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
    Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic spectra of biliary tract cancer.
    Nakamura H; Arai Y; Totoki Y; Shirota T; Elzawahry A; Kato M; Hama N; Hosoda F; Urushidate T; Ohashi S; Hiraoka N; Ojima H; Shimada K; Okusaka T; Kosuge T; Miyagawa S; Shibata T
    Nat Genet; 2015 Sep; 47(9):1003-10. PubMed ID: 26258846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated genomic analyses of hepatocellular carcinoma.
    Chang YS; Tu SJ; Chen HD; Hsu MH; Chen YC; Chao DS; Chung CC; Chou YP; Chang CM; Lee YT; Yen JC; Jeng LB; Chang JG
    Hepatol Int; 2023 Feb; 17(1):97-111. PubMed ID: 36472800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New genomic landscapes and therapeutic targets for biliary tract cancers.
    Simbolo M; Fassan M; Mafficini A; Lawlor RT; Ruzzenente A; Scarpa A
    Front Biosci (Landmark Ed); 2016 Jan; 21(4):707-18. PubMed ID: 26709801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening high risk populations for cancer: Hepatobiliary.
    Bailey A; Shah SA
    J Surg Oncol; 2019 Oct; 120(5):847-850. PubMed ID: 31309559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas.
    Shiraishi K; Okita K; Kusano N; Harada T; Kondoh S; Okita S; Ryozawa S; Ohmura R; Noguchi T; Iida Y; Akiyama T; Oga A; Fukumoto Y; Furuya T; Kawauchi S; Sasaki K
    Oncology; 2001; 60(2):151-61. PubMed ID: 11244331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations in hepatocellular carcinoma: An update.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
    Caruso S; Calatayud AL; Pilet J; La Bella T; Rekik S; Imbeaud S; Letouzé E; Meunier L; Bayard Q; Rohr-Udilova N; Péneau C; Grasl-Kraupp B; de Koning L; Ouine B; Bioulac-Sage P; Couchy G; Calderaro J; Nault JC; Zucman-Rossi J; Rebouissou S
    Gastroenterology; 2019 Sep; 157(3):760-776. PubMed ID: 31063779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
    Zucman-Rossi J; Villanueva A; Nault JC; Llovet JM
    Gastroenterology; 2015 Oct; 149(5):1226-1239.e4. PubMed ID: 26099527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.
    Totoki Y; Tatsuno K; Covington KR; Ueda H; Creighton CJ; Kato M; Tsuji S; Donehower LA; Slagle BL; Nakamura H; Yamamoto S; Shinbrot E; Hama N; Lehmkuhl M; Hosoda F; Arai Y; Walker K; Dahdouli M; Gotoh K; Nagae G; Gingras MC; Muzny DM; Ojima H; Shimada K; Midorikawa Y; Goss JA; Cotton R; Hayashi A; Shibahara J; Ishikawa S; Guiteau J; Tanaka M; Urushidate T; Ohashi S; Okada N; Doddapaneni H; Wang M; Zhu Y; Dinh H; Okusaka T; Kokudo N; Kosuge T; Takayama T; Fukayama M; Gibbs RA; Wheeler DA; Aburatani H; Shibata T
    Nat Genet; 2014 Dec; 46(12):1267-73. PubMed ID: 25362482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
    Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
    BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.